What is the address of CURINGE INVEST?

The registered office of CURINGE INVEST is located at Industrieterrein Kolmen 1107, 3570 Alken.

Is CURINGE INVEST still active?

Yes. According to the CBE (29 October 2026) CURINGE INVEST is active, legal situation “Normale toestand”, started on 20 September 2024.

Is CURINGE INVEST registered on Peppol?

Yes, CURINGE INVEST is registered on the Peppol network with ID 0208:1013870427.

What is the enterprise number of CURINGE INVEST?

The enterprise number of CURINGE INVEST is BE1013870427.

When was CURINGE INVEST founded?

CURINGE INVEST was founded on 20 September 2024.

Who are the directors of CURINGE INVEST?

According to the 2025 annual accounts, the directors of CURINGE INVEST are: Siedeco BV, Dekco BV, Vicco BV, Dethier Dries Consulting - vkt DEDRICO BV.

Is CURINGE INVEST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 September 2024; 1 annual account filed (fiscal year 2025); 4 directors known from the annual account.

How much profit did CURINGE INVEST make in 2025?

CURINGE INVEST recorded a loss after taxes of € 474,080 in financial year 2025.

What is the revenue of CURINGE INVEST?

As a small company, CURINGE INVEST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -19,742.

CURINGE INVEST (Public Limited) - Alken - BE1013870427

Dossier CURINGE INVEST, printed on 29 October 2026 from databakkes.be/en/1013870427/curinge-invest. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Busy address KBO

21 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

CURINGE INVEST from Alken, company number BE1013870427, closed financial year 2025 with a result of € -474,080 after tax. For that financial year CURINGE INVEST recorded a gross margin of € -19,742 and equity of € 25,920. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Healthy

€ 25,920

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -474,080

Profit after tax over the fiscal year.

Cash in the bank

€ 4,636

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -474,080.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.6 million

€ 137,500 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 75

Supplier invoices still open on the last day of the fiscal year.

What happened to CURINGE INVEST?

What happened at CURINGE INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Siedeco BV stepped down as director. NBB
2030 Dekco BV stepped down as director. NBB
2030 Vicco BV stepped down as director. NBB
2030 Dethier Dries Consulting - vkt DEDRICO BV stepped down as director. NBB
Jun 19, 2026 New annual accounts for financial year 2025: loss of € 474,080. Source: NBB ↗
Sep 20, 2024 New establishment in Alken. KBO
2024 Siedeco BV became a director. NBB
2024 Dekco BV became a director. NBB